339 related articles for article (PubMed ID: 2530729)
1. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
[TBL] [Abstract][Full Text] [Related]
2. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
3. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
[TBL] [Abstract][Full Text] [Related]
5. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
[TBL] [Abstract][Full Text] [Related]
6. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
Kitamura Y; Imai S; Matsueda R; Nomura Y
Mol Pharmacol; 1990 Aug; 38(2):184-91. PubMed ID: 2166901
[TBL] [Abstract][Full Text] [Related]
7. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
8. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
Carli M; Afkhami-Dastjerdian S; Reader TA
J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
[TBL] [Abstract][Full Text] [Related]
9. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
Alexander BS; Wood MD
J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
11. Mg2+ enhances high affinity [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding and guanine nucleotide modulation of serotonin-1a receptors.
DeVinney R; Wang HH
J Recept Signal Transduct Res; 1995 Apr; 15(5):757-71. PubMed ID: 8747885
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
13. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
Schlegel JR; Peroutka SJ
Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
[TBL] [Abstract][Full Text] [Related]
15. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
16. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
Uchitomi Y; Yamawaki S
Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment.
Welner SA; De Montigny C; Desroches J; Desjardins P; Suranyi-Cadotte BE
Synapse; 1989; 4(4):347-52. PubMed ID: 2532423
[TBL] [Abstract][Full Text] [Related]
18. Urapidil analogues are potent ligands of the 5-HT1A receptor.
Gross G; Schüttler K; Xin X; Hanft G
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491
[TBL] [Abstract][Full Text] [Related]
19. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
